Waiting
로그인 처리 중...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 22C3 Anti-PD-L1…
JoVE Journal
Cancer Research

JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.

JoVE Journal Cancer Research
22C3 Anti-PD-L1 抗体精矿在非小细胞肺癌活检及细胞学标本中的应用
 
Click here for the English version

22C3 Anti-PD-L1 抗体精矿在非小细胞肺癌活检及细胞学标本中的应用

Article DOI: 10.3791/58082-v • 07:43 min • September 25th, 2018
September 25th, 2018 •
1,2,3, 1, 1,2, 1,2, 1, 1, 1, 1,2,3, 1,2,3
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, 2Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, 3Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur

챕터

요약
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

为了扩大全世界实验室的能力, 以可靠和可重复的方式评估肺癌患者接受 pembrolizumab 治疗的资格, 我们开发了一种使用22C3 抗体集中于广泛应用的检测方法。免疫组化 autostainer, 用于活检和细胞学标本。

Tags

癌症研究 问题 139 PD-L1 LDT 免疫组化 活检 细胞学 非小细胞肺癌
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter